Tan Lijie

2 clinical trials · Sponsor

Record	Firm	Date
An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging (NCT07770672)	Tan Lijie	2026-08-20

Every clearance here is in the API, with alerts when new ones post.